UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
                                  _____________

                                    Form 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reportedly): July 25, 2005


                              OCEAN BIO-CHEM, INC.
               (Exact name of registrant as specified in charter)


          Florida                        2-70197                59-1564329
(State or Other Jurisdiction     (Commission File Number)    (I.R.S. Employer
    of Incorporation)                                        Identification No.)

               4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
                (Address of principal executive office Zip Code)

                                 (954) 587-6280
               Registrant's telephone number, including area code:

                                 Not Applicable
          (Former name or former address, if changes since last report)

     Check the  appropriate  box below if the Form 8-K  filing  is  intended  to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

     [ ] Written  communications  pursuant to Rule 425 under the  Securities Act
(17 CFR 230.425)

     [ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     [ ]  Pre-commencement  communications  pursuant to Rule 14d-2(b)  under the
Exchange Act (17 CFR 240.14d-2(b))

     [ ]  Pre-commencement  communications  pursuant to Rule 13e-4(c)  under the
Exchange Act (17 CFR 240.13e-4(c))




Item 5.02 - Departure of Directors or Principal Officers; Election of Directors;
            Appointment of Principal Officers

     (c) On July 25, 2005,  the Company's  Board of Directors  elected Gregor M.
Dornau Vice President of the Company.  Gregor is 36 years old, is the son of our
Chairman and CEO,  Peter G. Dornau and has been an employee of the Company since
1990. He currently  serves as our National  Sales  Manager.  He will continue to
function  in that  capacity  as well as  expand  his  responsibilities  to other
corporate matters as needed.  There is no written  employment  agreement between
him and the Company and he will continue  working under the current terms of his
employment.


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


July 25, 2005
                                 Ocean Bio-Chem, Inc.


                                 /s/ Peter G. Dornau
                                 Peter G. Dornau
                                 Chairman of the Board and
                                 Chief Executive Officer